19th ICASA | 4 - 9 DEC 2017 | ABIDJAN | CÔTE D'IVOIRE
INTERNATIONAL CONFERENCE ON AIDS AND STIs IN AFRICA
ICASA 2017 Côte d'Ivoire > Track Description > Track B: Clinical Science, Treatment and Care
Go Back

Track B: Clinical Science, Treatment and Care

Source:

Description: This track will analyze clinical features of opportunistic infections, malignancies, severe bacterial diseases, co-morbidities in people living with HIV. Issues in antiretroviral therapy, response to ART, adherence, retention, long term follow -up, management of side effects, ART in specific populations (adolescents, Elderly, pregnant women) will also be addressed. Emerging topics such as aging, frailty and in other age-related comorbidities such as cardiovascular, renal, neurocognitive, bone mineral and metabolic diseases will be discussed. Issues of resistance and management of failure including salvage therapy which is a concern in resources limited settings will be addressed.

Abstract Categories
Clinical course of HIV infection and disease

B1. Natural history of HIV Disease including markers of HIV Disease progression
B2. Challenges associated with pre-ART patient care
B3. Morbidity and mortality/life expectancy during ART
B4Acute and early infection

Diagnosis and management of co-infections/co-morbidities

B5. Co-infections (TB, Hepatitis, STIs, Cryptococcus, bacterial diseases, leishmaniosis, Malaria and others)
B6. Prophylaxis against common infections (CPT, IPT, antifungal)
B7 immunization in HIV infected people
B8 Diagnosis and management of Hepatitis B/C
B9- Tools for diagnosis and management of infections: point of care

HIN and NCD

B10. diabetes, cardiovascular, renal diseases, bone mineral diseases, HIV and neurocognitive disorders)
B11. HIV and malignancies
B12 HIV, Ageing and Fragility
B13 Diagnosis and management of STI
B14 Syphilis, HPV and others

 

Antiretroviral therapy

B15. First line therapy (when to start, what to start with, durability)
B16. ART monit oring strategies
B17. Treatment failure: drug resistance, second line therapy and salvage therapy
B18. Adherence and retention
B19. Antiretroviral therapy in children
B20. HIV management in adolescents
B21. Antiretroviral therapy in pregnant women
B22 Antiretroviral therapy in elder populations
B23. Adverse effects of antiretroviral therapy including immune reconstitution syndrome be sure Track C integrate this (quality of life…)
B24. HIV-2, HIV-1+2 infections
B25 Management of HIV infection in Key Populations
B26. Cost effectiveness of ART
B27. Antiretroviral therapy to prevent HIV-Transmission
B28 ART maintenance simplification

Palliative care and nutrition

B29. Pain management and end of life care
B30. Clinical nutritional care in HIV infection
B31. Home and community based care and support
B32 Other Strategies and Therapies (traditional medicine, spiritual care)

Clinical guidelines, tools and algorithms

B33. Country adaptation of global HIV diagnosis and treatment guidelines
B34. Diagnosis and monitoring tools


Leave a Comment or Questions

Time limit is exhausted. Please reload CAPTCHA.

ONGOING
ACCOMMODATION
SECURE YOUR VISA
OFFICIAL CARRIER OF ICASA 2017
MEMORY OF ICASA 2015